Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,019 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).
Saeki H, Nakagawa H, Nakajo K, Ishii T, Morisaki Y, Aoki T, Cameron GS, Osuntokun OO; Japanese Ixekizumab Study Group. Saeki H, et al. J Dermatol. 2017 Apr;44(4):355-362. doi: 10.1111/1346-8138.13622. Epub 2016 Oct 11. J Dermatol. 2017. PMID: 27726163 Free PMC article. Clinical Trial.
Long-term efficacy and safety results from an open-label phase III study (UNCOVER-J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab.
Umezawa Y, Torisu-Itakura H, Morisaki Y, ElMaraghy H, Nakajo K, Akashi N, Saeki H; Japanese Ixekizumab Study Group. Umezawa Y, et al. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):568-576. doi: 10.1111/jdv.15292. Epub 2018 Nov 13. J Eur Acad Dermatol Venereol. 2019. PMID: 30325534 Free PMC article. Clinical Trial.
Pemphigoid nodularis associated with pembrolizumab in a lung cancer patient.
Yamamoto M, Hashimoto T, Okuzawa M, Yashiki K, Okuno S, Awatani-Yoshidome K, Akaishi N, Satoh T. Yamamoto M, et al. Among authors: hashimoto t. Eur J Dermatol. 2023 Feb 1;33(1):53-54. doi: 10.1684/ejd.2023.4418. Eur J Dermatol. 2023. PMID: 37178038 No abstract available.
A case of anti-p200 pemphigoid after COVID-19 vaccination.
Shimamoto K, Someda Y, Ushimura A, Tateishi C, Hayashi D, Tsuruta D, Hashimoto T, Goto H. Shimamoto K, et al. Among authors: hashimoto t. Eur J Dermatol. 2024 Apr 1;34(2):220-221. doi: 10.1684/ejd.2024.4665. Eur J Dermatol. 2024. PMID: 38907563 No abstract available.
7,019 results